ALPS Advisors’s MEI Pharma MEIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,834
| Closed | -$82K | – | 1074 |
|
|
2022
Q1 | $82K | Sell |
6,834
-699
| -9% | -$8.39K | ﹤0.01% | 830 |
|
|
2021
Q4 | $402K | Buy |
7,533
+628
| +9% | +$33.5K | ﹤0.01% | 657 |
|
|
2021
Q3 | $381K | Sell |
6,905
-510
| -7% | -$28.1K | ﹤0.01% | 609 |
|
|
2021
Q2 | $423K | Sell |
7,415
-2,764
| -27% | -$158K | ﹤0.01% | 557 |
|
|
2021
Q1 | $698K | Buy |
10,179
+106
| +1% | +$7.27K | 0.01% | 445 |
|
|
2020
Q4 | $532K | Buy |
10,073
+2,898
| +40% | +$153K | 0.01% | 485 |
|
|
2020
Q3 | $448K | Sell |
7,175
-56
| -0.8% | -$3.5K | 0.01% | 474 |
|
|
2020
Q2 | $597K | Buy |
+7,231
| New | +$597K | 0.01% | 426 |
|
|
2019
Q2 | – | Sell |
-8,593
| Closed | -$528K | – | 894 |
|
|
2019
Q1 | $528K | Buy |
8,593
+374
| +5% | +$23K | ﹤0.01% | 493 |
|
|
2018
Q4 | $434K | Buy |
+8,219
| New | +$434K | ﹤0.01% | 531 |
|